word count: 238Manuscript word count: 1907
Conflict of interest / Financial DisclosureDudley Robinson received funding from Astellas Pharma, Pfizer, Allergan, Ferring, and SEP. Phillipe Grange received funding for research, lecturing, and/or advice or consultancies from Johnson & Johnson and Prosurgics. Linda Cardozo received funding for research, lecturing, and/or advice or consultancies from Astellas Pharma, AMS, Pfizer, and Allergan. She is a member of Global Advisory Board for Solifenancin, co-chairman of the European overactive bladder forum, principal investigator for the SUNRISE study, and speaker at satellite symposia for Astellas Pharma. She is also a member of the Global Advisory Board for Fesoterodine and participant in a multicentre research study. The other authors report no relevant financial interests.
Results:We here report 5 cases referred to our team with tape erosions that were treated with vesicoscopic excision of the material and primary closure of the urothelial defect. The foreign material was completely removed in all cases and there is no recurrence at a median follow-up of 30 months.
Conclusion:Vesicoscopic excision of bladder eroded foreign material is feasible and efficient. We recommend this technique to be considered as primary approach to tapes eroding into the bladder.